Ligand validation:8EVY

DAL: D-ALANINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8EVY_DAL_A_402	81%	35%	0.118	0.969	1.21	1.33	1	1	0	0	100%	0.94
8EVY_DAL_C_402	64%	36%	0.173	0.973	1.16	1.36	1	1	0	0	100%	0.87
8EVY_DAL_B_402	62%	35%	0.181	0.975	1.13	1.41	1	1	0	0	100%	0.93
8EVY_DAL_B_401	56%	63%	0.181	0.984	0.63	0.79	-	-	0	0	83%	0.8333
8EVY_DAL_A_401	55%	63%	0.18	0.98	0.64	0.77	-	-	0	0	83%	0.8333
8EVY_DAL_C_401	33%	63%	0.256	0.968	0.63	0.8	-	-	0	0	83%	0.8333
1C0P_DAL_A_1364	98%	15%	0.054	0.977	1.92	1.85	2	2	5	0	100%	1
8EVW_DAL_B_603	97%	37%	0.076	0.989	1.58	0.92	1	-	0	0	100%	1
4G4Z_DAL_A_401	93%	65%	0.075	0.971	0.65	0.71	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.